ABVC BioPharma Inc. (ABVC)
NASDAQ: ABVC
· Real-Time Price · USD
2.97
0.01 (0.34%)
At close: Oct 14, 2025, 1:13 PM
ABVC BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 509.59K | 152.43K | 969.78K | 355.8K |
Cost of Revenue | 763.00 | 302.04K | 286.42K | 5.09K |
Gross Profit | 508.83K | -150K | 683.37K | 350.71K |
Operating Income | -4.71M | -6.77M | -15.11M | -11.71M |
Interest Income | 87.36K | 185.48K | 187.82K | 43.2K |
Pretax Income | -5.37M | -8.03M | -15.52M | -11.21M |
Net Income | -4.9M | -7.79M | -16.42M | -12.84M |
Selling & General & Admin | 5.04M | 5.55M | 13.1M | 11.05M |
Research & Development | 179.27K | 1.06M | 2.69M | 1M |
Other Expenses | -272 | -211 | 1K | n/a |
Operating Expenses | 5.21M | 6.62M | 15.8M | 12.06M |
Interest Expense | 825.9K | 1.31M | 293.97K | 227.21K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.21M | 6.92M | 16.08M | 12.06M |
Income Tax Expense | -111K | 256.01K | 797.78K | 825.02K |
Shares Outstanding (Basic) | 11.67M | 4.34M | 3.17M | 2.5M |
Shares Outstanding (Diluted) | 11.67M | 4.34M | 3.17M | 2.5M |
EPS (Basic) | -0.42 | -1.8 | -5.2 | -5.1 |
EPS (Diluted) | -0.42 | -1.8 | -5.2 | -5.1 |
EBITDA | -4.34M | -6.33M | -15.2M | -10.97M |
EBIT | -4.54M | -6.71M | -15.22M | -10.98M |
Depreciation & Amortization | 200.92K | 380.39K | 23.8K | 11.99K |